AG真人官方

Edesa Biotech (Nasdaq: EDSA) has filed a replacement Form S-3 shelf registration allowing it to issue up to $150 million of common or preferred shares, warrants, debt, subscription rights or units on a from-time-to-time basis. The shelf refreshes unsold securities remaining under the company鈥檚 August 2022 shelf (File No. 333-266604) and will become effective once declared by the SEC, automatically terminating the prior shelf under Rule 415(a)(6).

As of 25-Jul-2025 Edesa鈥檚 public float is $13.94 million (5.74 million non-affiliate shares at $2.43). Under Instruction I.B.6 the company may not sell securities with an aggregate value exceeding one-third of that float (<鈮�$4.65 million) in any 12-month period while float remains below $75 million; it has sold $0.84 million during the last 12 months.

The filing preserves capital-raising flexibility to fund working capital and general corporate purposes, notably development of its dermatology (EB06, EB01) and respiratory (EB05/EB07) pipelines. No immediate securities are being offered and pricing, amounts and underwriters will be set by future prospectus supplements. Existing shareholders face dilution risk from potential equity issuance; however, the shelf helps ensure liquidity for ongoing clinical programs.

Form 4 highlights: On 24-Jul-2025, SM Energy (SM) Senior Vice President 鈥� Business Development & Land Kenneth J. Knott reported insider equity transactions. A performance share unit (PSU) award vested, issuing 3,458 common shares to Knott (Code M). To satisfy tax withholding, 843 shares were disposed of at $24.71 each (Code F). His direct holdings after settlement total 134,235 common shares.

On 25-Jul-2025 Knott also received 15,361 restricted stock units (RSUs) that vest in six equal biannual installments starting 1-Jan-2026. Each RSU converts to one common share upon vesting, bringing his derivative holdings to 15,361 RSUs.

The net effect is an incremental 2,615-share increase in direct ownership, modestly reinforcing management-shareholder alignment. Given SM鈥檚 large public float, the dollar value is immaterial at the corporate level, implying limited market impact.

MarketWise, Inc. (MKTW) 鈥� Form 4 insider filing

Director and >10% shareholder Frank Porter Stansberry reported the award of 6,775 Class A restricted stock units (RSUs) on 12-Jun-2025. The RSUs carry a grant price of $0 and will vest on the earlier of the day before the 2026 annual meeting or 12-Jun-2026, contingent on continued board service.

Following the grant, Stansberry鈥檚 direct beneficial ownership stands at 210,008 Class A shares. Share counts in the filing are adjusted to reflect MarketWise鈥檚 1-for-20 reverse stock split that became effective 2-Apr-2025.

No derivative securities were reported, and the transaction was coded 鈥淎鈥� (award) rather than an open-market purchase or sale.

Form 144 filed for Sight Sciences, Inc. (SGHT) discloses a contemplated insider disposition of 5,679 common shares through Fidelity Brokerage Services on 07 / 03 / 2025. At the most recent market price, the block is valued at $23,705.28. With 51,702,088 shares outstanding, the proposed sale equates to just 0.011 % of the float, suggesting minimal market impact.

The seller acquired the shares via restricted-stock vesting on 06 / 30 / 2025 as compensation. No other sales were reported in the past three months, and the filer attests to possessing no undisclosed adverse information. Under Rule 144, the notice creates a 90-day window in which the shares may be sold; actual execution will be confirmed, if it occurs, by a subsequent Form 4.

Although the dollar amount is immaterial in relation to SGHT鈥檚 capitalization, investors often view any insider sale as a potential sentiment signal. Monitoring future filings will clarify whether this event reflects routine liquidity or the start of a broader selling pattern.

Form 144 filed for Sight Sciences, Inc. (SGHT) discloses a contemplated insider disposition of 5,679 common shares through Fidelity Brokerage Services on 07 / 03 / 2025. At the most recent market price, the block is valued at $23,705.28. With 51,702,088 shares outstanding, the proposed sale equates to just 0.011 % of the float, suggesting minimal market impact.

The seller acquired the shares via restricted-stock vesting on 06 / 30 / 2025 as compensation. No other sales were reported in the past three months, and the filer attests to possessing no undisclosed adverse information. Under Rule 144, the notice creates a 90-day window in which the shares may be sold; actual execution will be confirmed, if it occurs, by a subsequent Form 4.

Although the dollar amount is immaterial in relation to SGHT鈥檚 capitalization, investors often view any insider sale as a potential sentiment signal. Monitoring future filings will clarify whether this event reflects routine liquidity or the start of a broader selling pattern.

Form 144 filed for Sight Sciences, Inc. (SGHT) discloses a contemplated insider disposition of 5,679 common shares through Fidelity Brokerage Services on 07 / 03 / 2025. At the most recent market price, the block is valued at $23,705.28. With 51,702,088 shares outstanding, the proposed sale equates to just 0.011 % of the float, suggesting minimal market impact.

The seller acquired the shares via restricted-stock vesting on 06 / 30 / 2025 as compensation. No other sales were reported in the past three months, and the filer attests to possessing no undisclosed adverse information. Under Rule 144, the notice creates a 90-day window in which the shares may be sold; actual execution will be confirmed, if it occurs, by a subsequent Form 4.

Although the dollar amount is immaterial in relation to SGHT鈥檚 capitalization, investors often view any insider sale as a potential sentiment signal. Monitoring future filings will clarify whether this event reflects routine liquidity or the start of a broader selling pattern.

Form 144 filed for Sight Sciences, Inc. (SGHT) discloses a contemplated insider disposition of 5,679 common shares through Fidelity Brokerage Services on 07 / 03 / 2025. At the most recent market price, the block is valued at $23,705.28. With 51,702,088 shares outstanding, the proposed sale equates to just 0.011 % of the float, suggesting minimal market impact.

The seller acquired the shares via restricted-stock vesting on 06 / 30 / 2025 as compensation. No other sales were reported in the past three months, and the filer attests to possessing no undisclosed adverse information. Under Rule 144, the notice creates a 90-day window in which the shares may be sold; actual execution will be confirmed, if it occurs, by a subsequent Form 4.

Although the dollar amount is immaterial in relation to SGHT鈥檚 capitalization, investors often view any insider sale as a potential sentiment signal. Monitoring future filings will clarify whether this event reflects routine liquidity or the start of a broader selling pattern.

MarketWise, Inc. (MKTW) 鈥� Form 4 insider transaction dated 06/12/2025

Director Van D. Simmons received an award of 6,775 Class A restricted stock units (RSUs) at no cost (Transaction Code 鈥淎鈥�). After the grant, his direct beneficial ownership stands at 18,160 shares. The RSUs vest on the earlier of (i) the day immediately preceding the 2026 Annual Meeting of Shareholders or (ii) 12 June 2026, provided he remains on the board. Share totals already reflect the 1-for-20 reverse split executed on 02 April 2025. The delayed filing date is attributed to an administrative error, not to the reporting person.